Prestige Consumer Healthcare (PBH) Interest & Investment Income (2011 - 2020)
Prestige Consumer Healthcare (PBH) posted quarterly Interest & Investment Income of $24000.0 for Q2 2020, down 44.19% year-over-year from $43000.0 in Q3 2019, and up 9.09% quarter-over-quarter from $22000.0 in Q1 2020.
Prestige Consumer Healthcare (PBH) Interest & Investment Income (2011 - 2020) Analysis & Trends
Prestige Consumer Healthcare's Interest & Investment Income history runs 10 years deep, the most recent figure standing at $24000.0 for Q2 2020.
- In Q2 2020, Interest & Investment Income fell 44.19% year-over-year to $24000.0; the TTM figure through Jun 2020 stood at $323000.0 (up 101.87% YoY), while the FY2020 annual figure was $342000.0, up 57.6% from the prior year.
- Interest & Investment Income for Q2 2020 stood at $24000.0, up from $22000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $245000.0 in Q4 2019, with the low at $22000.0 in Q1 2020.
- The 5-year median for Interest & Investment Income is $50000.0 (2016), against an average of $69166.7.
- The sharpest annual moves came in 2018 and 2019: Interest & Investment Income tumbled 67.23% in 2018, then jumped 528.21% in 2019.
- Prestige Consumer Healthcare's Interest & Investment Income stood at $46000.0 in 2016, then surged by 158.7% to $119000.0 in 2017, then sank by 67.23% to $39000.0 in 2018, then surged by 528.21% to $245000.0 in 2019, then tumbled by 90.2% to $24000.0 in 2020.
- Business Quant data shows PBH's Interest & Investment Income at $24000.0 in Q2 2020, $22000.0 in Q1 2020, and $245000.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 154.39 Mn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 31.50 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 12.40 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.42 Bn | 2.36 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 24,000.00 |
| Mar 31, 2020 | 22,000.00 |
| Dec 31, 2019 | 245,000.00 |
| Sep 30, 2019 | 32,000.00 |
| Jun 30, 2019 | 43,000.00 |
| Mar 31, 2019 | 45,000.00 |
| Dec 31, 2018 | 39,000.00 |
| Sep 30, 2018 | 33,000.00 |
| Jun 30, 2018 | 100,000.00 |
| Mar 31, 2018 | 115,000.00 |
| Dec 31, 2017 | 119,000.00 |
| Sep 30, 2017 | 85,000.00 |
| Jun 30, 2017 | 69,000.00 |
| Mar 31, 2017 | 54,000.00 |
| Dec 31, 2016 | 46,000.00 |
| Sep 30, 2016 | 46,000.00 |
| Jun 30, 2016 | 57,000.00 |
| Mar 31, 2016 | 71,000.00 |
| Dec 31, 2015 | 31,000.00 |
| Sep 30, 2015 | 33,000.00 |